IL-17A inhibitors modulate skin microbiome in psoriasis: implications for microbial homeostasis
Abstract Background The IL-17A inhibitors target aberrant immune responses in psoriasis but also impacts the host’s defense against infections. The effects of this treatment on skin microorganisms and microbiome-encoded metabolic pathways remain unclear. Objectives This was an exploratory clinical s...
Saved in:
| Main Authors: | Ying Lv, Huiying Bian, Yanjia Jing, Jing Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12967-025-06723-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aspectos de la IL-17 en la inmunopatogénesis de la psoriasis: un nuevo blanco terapéutico
by: Luis Carlos Ramírez, et al.
Published: (2019-08-01) -
Assessment of The Impact of Apremilast on Levels of IL-17, IL-23, and Lipids in Obese Psoriatic Patient
by: Haitham M. Saad, et al.
Published: (2024-12-01) -
Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience
by: Gioele Ghezzi, et al.
Published: (2024-11-01) -
Efficacy of interleukin-17 inhibitors in psoriasis patients: a comparative non-randomized study
by: Arfenya E. Karamova, et al.
Published: (2025-06-01) -
The Contribution of the Skin Microbiome to Psoriasis Pathogenesis and Its Implications for Therapeutic Strategies
by: Diana Sabina Radaschin, et al.
Published: (2024-10-01)